Corona Remedies consolidated net profit rises 43.68% in the March 2026 quarter

Sales rise 20.23% to Rs 353.09 crore

Net profit of Corona Remedies rose 43.68% to Rs 45.33 crore in the quarter ended March 2026 as against Rs 31.55 crore during the previous quarter ended March 2025. Sales rose 20.23% to Rs 353.09 crore in the quarter ended March 2026 as against Rs 293.69 crore during the previous quarter ended March 2025.

For the full year,net profit rose 23.88% to Rs 185.12 crore in the year ended March 2026 as against Rs 149.43 crore during the previous year ended March 2025. Sales rose 17.28% to Rs 1403.18 crore in the year ended March 2026 as against Rs 1196.42 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	353.09	293.69	20	1403.18	1196.42	17
OPM %	17.56	18.46	-	20.91	20.06	-
PBDT	65.03	53.65	21	297.39	235.69	26
PBT	54.74	43.61	26	259.52	198.53	31
NP	45.33	31.55	44	185.12	149.43	24

Powered by Capital Market - Live News